NOVATO, California, 5 de junio de 2026 /PRNewswire-HISPANIC PR WIRE/ -- Brayton Purcell LLP está llamando la atención sobre un artículo...
The Canada Nation
Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin Use NEW ORLEANS, June...
FRANKLIN, Tenn., June 5, 2026 /PRNewswire/ -- Xsolis, Inc. ("Xsolis"), a vendor that provides case and utilization management services to...
New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney disease ZHUBEI...
A phase 2 study of investigational once-weekly subcutaneous zenagamtide showed statistically significant reductions in blood sugar in adults with type...
Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach to Early...
AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates The dataset was shared as part of a poster...
Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully...
Each recipient received $3,000 to support their future higher education goals.SANTA ANA, Calif., June 5, 2026 /PRNewswire/ -- Think Together,...
As an adult, a point may arrive when you realize that your aging parents or other older relatives could use...